JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management
Editor's Note: Metabolic-associated steatotic liver disease (MASLD) has become the fastest-growing cause of hepatocellular carcinoma (HCC). A recent multicenter clinical study led by Dr. Carole Vitellius from Angers University Hospital,…